These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24079257)

  • 1. [Influence and countermeasure of technical barriers to trade on traditional Chinese medicine industry].
    Gao J; Dong L; Song ZH
    Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2214-7. PubMed ID: 24079257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research on competitiveness of traditional Chinese medicine industry's international trade based on diamond theory].
    Cheng M; Yang G; Chi XL; Xin MT
    Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(1):199-203. PubMed ID: 30868833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restricting factors and countermeasures of Yunnan traditional Chinese medicine industry development].
    Xin W; Zhang W; Wang W; Liu Z
    Zhongguo Zhong Yao Za Zhi; 2012 May; 37(10):1509-12. PubMed ID: 22860472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Theory of toxic classification of traditional Chinese medicine and recommendations for revision of China pharmacopeia (volume 1)].
    Zhao J; Ye Z
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2193-8. PubMed ID: 23189716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the WTO/TBT enquiry point to monitor tendencies in the regulation of environment, health, and safety issues affecting the chemical industry.
    Pio Borges Menezes R; Maria de Souza Antunes A
    Environ Int; 2005 Apr; 31(3):407-16. PubMed ID: 15734193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on influential factors in China's exports of primary and semi-finished products of traditional Chinese medicine to ASEAN].
    Qian YX; Yang Y; Zhao W; Bi KS
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1321-5. PubMed ID: 25011277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis on layout of traditional Chinese medicine industry based on location quotient].
    Chen C; Yu Y; Hu Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(5):549-52. PubMed ID: 22693891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of problems and causes in industrial chain of traditional Chinese medicine].
    Li Q; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(16):2214-6. PubMed ID: 21046764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will the Europe Union's Traditional Herbal Medicinal Products Directive (Directive 2004/24/EC) be against traditional Chinese medicine in EU market?
    Xu J; Liu M; Xia Z
    J Evid Based Med; 2013 May; 6(2):104-8. PubMed ID: 23829802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prudent use price controls in Chinese medicines market: based on statistical data analysis].
    Yang G; Wang N; Huang LQ; Qiu HY; Guo LP
    Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):144-8. PubMed ID: 24754184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discussion on clinical problems about bases of new drug of traditional Chinese medicine development].
    Guo J; Dong Y; Tang JY
    Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):844-847. PubMed ID: 28994523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difficulties in registration for export of traditional Chinese medicines to EU under directive 2004/24/EC and countermeasures].
    Ni HX; Sun YY
    Zhongguo Zhong Yao Za Zhi; 2013 May; 38(9):1447-50. PubMed ID: 23944086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.
    Chan K; Shaw D; Simmonds MS; Leon CJ; Xu Q; Lu A; Sutherland I; Ignatova S; Zhu YP; Verpoorte R; Williamson EM; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):469-75. PubMed ID: 22330011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities.
    Uzuner H; Bauer R; Fan TP; Guo DA; Dias A; El-Nezami H; Efferth T; Williamson EM; Heinrich M; Robinson N; Hylands PJ; Hendry BM; Cheng YC; Xu Q
    J Ethnopharmacol; 2012 Apr; 140(3):458-68. PubMed ID: 22387462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge discovery in traditional Chinese medicine: state of the art and perspectives.
    Feng Y; Wu Z; Zhou X; Zhou Z; Fan W
    Artif Intell Med; 2006 Nov; 38(3):219-36. PubMed ID: 16930966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Scientific supervision of compound preparation of traditional Chinese medicine and chemical drug].
    Yu J; Yu B; Qian Z
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1542-6. PubMed ID: 22779196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Traditional Chinese medicine properties and traditional Chinese medicine property-matteromics].
    Liu PX; Long W
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(14):1769-71. PubMed ID: 18841785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the consistency of traditional Chinese medicine with multiple correlative active components.
    Lu Q; Chow SC; Tse SK
    J Biopharm Stat; 2007; 17(5):791-808. PubMed ID: 17885866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.